Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angiogenesis
100%
Hepatocellular Carcinoma
100%
Interleukin-6
100%
4-methylumbelliferone
100%
Hyaluronic Acid
23%
Fibrosis
15%
CD31
15%
Tube Formation
15%
Liver Parenchyma
15%
Chemokine Ligand 12 (CXCL12)
15%
Endothelial Cells
7%
Tumor Growth
7%
Tumor Cells
7%
Mechanism of Action
7%
Tumor Microenvironment
7%
Orally Administered
7%
Cirrhosis
7%
Cell Formation
7%
Protein Level
7%
Kupffer Cells
7%
Anticancer Activity
7%
MRNA Level
7%
Male Mice
7%
Immunostaining
7%
Tumor Tissue
7%
Extracellular Matrix Protein 1 (ECM1)
7%
Comparisons with a Control
7%
Angiogenesis Inhibitors
7%
Angiogenic Factors
7%
Acid Inhibition
7%
Thioacetamide
7%
Transendothelial Migration
7%
Endothelial Tubes
7%
Hepatocellular Carcinoma Treatment
7%
Orthotopic Hepatocellular Carcinoma
7%
Preneoplastic Condition
7%
Animal Survival
7%
Hepatocellular Carcinoma Model
7%
Vascular Endothelial Growth Factor, VEGF
7%
Antitumor in Vivo
7%
Immunology and Microbiology
Interleukin 6
100%
Angiogenesis
100%
Vasculotropin
57%
Antineoplastic Activity
28%
CD31
28%
Liver Parenchyma
28%
In Vitro
28%
Endothelial Cells
28%
Kupffer Cell
14%
Antiangiogenic Activity
14%
Tumor Cell
14%
Immunostaining
14%
Chemokine
14%
Extracellular Matrix
14%
Cell Migration
14%
Cirrhosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Interleukin 6
100%
Hymecromone
100%
Vasculotropin
30%
Hyaluronic Acid
23%
Neoplasm
15%
Fibrosis
15%
Antitumor Activity
7%
Thioacetamide
7%
Chemokine
7%
Tumor Growth
7%
Liver Cirrhosis
7%
Tumor Microenvironment
7%
Messenger RNA
7%